Hospital survival following pediatric HSCT: changes in complications, ICU therapies and outcomes over 10 years

INTRODUCTION: Hematopoietic stem cell transplantation (HSCT) is an increasingly utilized therapy for malignant and non-malignant pediatric diseases. HSCT complications, including infection, organ dysfunction, and graft-versus-host-disease (GVHD) often require intensive care unit (ICU) therapies and...

Descripción completa

Detalles Bibliográficos
Autores principales: Olson, Taylor L., Pollack, Murray M., Dávila Saldaña, Blachy J., Patel, Anita K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601648/
https://www.ncbi.nlm.nih.gov/pubmed/37900687
http://dx.doi.org/10.3389/fped.2023.1247792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601648/
https://www.ncbi.nlm.nih.gov/pubmed/37900687
http://dx.doi.org/10.3389/fped.2023.1247792

Ejemplares similares